Quince Therapeutics
QNCX
QNCX
61 hedge funds and large institutions have $12.4M invested in Quince Therapeutics in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less capital invested
Capital invested by funds: $26M → $12.4M (-$13.6M)
54% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 26
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
61
Holding in Top 10
–
Calls
$361K
Puts
$403K
Top Buyers
| 1 | +$650K | |
| 2 | +$150K | |
| 3 | +$146K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$112K |
| 5 |
Renaissance Technologies
New York
|
+$72.9K |
Top Sellers
| 1 | -$1.62M | |
| 2 | -$705K | |
| 3 | -$445K | |
| 4 |
Morgan Stanley
New York
|
-$411K |
| 5 |
ECM
Evolution Capital Management
Crystal Bay,
Nevada
|
-$393K |